This report was sent to Briefing.com subscribers earlier today.
Research calls posted earlier this morning are available here.
Upgrades:
> Columbia Banking (COLB) upgraded to Overweight from Neutral at Piper Sandler; tgt $32
> Dr. Reddy’s (RDY) upgraded to Buy from Neutral at BofA Securities
> SAP SE (SAP) upgraded to Outperform from Neutral at Exane BNP Paribas; tgt $143
Downgrades:
> Bath & Body Works (BBWI) downgraded to Hold from Buy at Argus
> First Republic Bank (FRC) downgraded to Neutral from Overweight at Argus
> Konami Holdings (KNMCY) downgraded to Underperform from Buy at CLSA
> Sage plc (SGPYY) downgraded to Neutral from Outperform at Exane BNP Paribas
> Xero (XROLF) downgraded to Outperform from Buy at CLSA
Others:
> Autolus Therapeutics (AUTL) initiated with a Buy at Bryan Garnier; tgt $5
> Cellectis (CLLS) initiated with a Buy at Bryan Garnier; tgt $6
> CRISPR Therapeutics (CRSP) initiated with a Buy at Bryan Garnier; tgt $70
> FactSet (FDS) initiated with an Outperform at CICC; tgt $500
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
